Risperidone + Trihexyphenidyl Tablet Franchise Company in Gujarat

PCD Pharma for Risplom 2T MD Tablet in Maharashtra

Risperidone + Trihexyphenidyl 2mg Tablet Supplier in Uttar Pradesh

Neuropsychiatry Range – Risplom 2T MD Tablet Manufacturer in Baddi

Risperidone + Trihexyphenidyl Combination Tablet PCD Franchise in Punjab
Top Risperidone + Trihexyphenidyl Tablet Exporter from India

Home/Products /risperidone-ip-2mg-trihexyphenidyl-hydrochloride-ip-2mg-tablet

About the Product

Description


Risplom 2T MD Tablet is a dual-action formulation that combines the therapeutic effects of Risperidone, an atypical antipsychotic, and Trihexyphenidyl, an anticholinergic agent. This unique combination is specifically designed to address both the psychotic symptoms of conditions such as schizophrenia and the motor side effects often associated with long-term antipsychotic therapy. Risperidone functions by modulating neurotransmitters like dopamine and serotonin in the brain, helping to improve mood, thought clarity, emotional regulation, and reduce hallucinations or delusions. However, such medications may lead to extrapyramidal symptoms (EPS), including tremors, rigidity, or involuntary muscle movements. To counter this, Trihexyphenidyl is added to mitigate these EPS by restoring the balance between acetylcholine and dopamine in the central nervous system. Together, they create a more tolerable and effective long-term management option for psychiatric disorders. This combination is especially useful in patients who are sensitive to EPS or who have a history of movement disorders when treated with antipsychotics alone. It ensures not just symptom control but also better medication adherence and quality of life.

Common side effects may include drowsiness, dizziness, dry mouth, blurred vision, constipation, and weight gain. Serious but rare effects may include worsening of psychiatric symptoms, confusion, or involuntary muscle movements. Patients should report any unusual changes in behavior or movement.

This medication is indicated for the treatment of schizophrenia and related psychotic disorders in patients who require both antipsychotic control and management of drug-induced movement disorders (extrapyramidal symptoms).

Use with caution in patients with glaucoma, cardiac issues, urinary retention, or history of seizures. Alcohol and other CNS depressants should be avoided during therapy. Activities requiring full mental alertness (like driving) should be performed carefully.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Risperidone IP 2mg + Trihexyphenidyl Hydrochloride IP 2mg Tablet in the PCD pharma franchise market?

Risperidone IP 2mg + Trihexyphenidyl Hydrochloride IP 2mg Tablet has consistent demand in the psychiatry, neurology, and mental healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on CNS (Central Nervous System) and specialty pharmaceutical portfolios.

Why should medical distributors include Risperidone IP 2mg + Trihexyphenidyl Hydrochloride IP 2mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for psychiatric disorder management under specialist medical supervision. Risperidone 2mg is an atypical antipsychotic indicated for the treatment of schizophrenia, bipolar disorder, and certain other psychiatric conditions, as advised by healthcare professionals Trihexyphenidyl Hydrochloride 2mg is an anticholinergic agent used to help prevent or reduce extrapyramidal symptoms (EPS) such as tremors, rigidity, and muscle stiffness that may occur with antipsychotic therapy in selected patients This combination may be prescribed for patients requiring antipsychotic treatment while also needing management of drug-induced extrapyramidal symptoms, based on the psychiatrist's clinical judgment. Routine prophylactic use of anticholinergics is not recommended for all patients and should be individualized The oral tablet formulation offers convenient once- or twice-daily administration as directed by the treating physician and supports long-term treatment adherence when appropriate Treatment should be initiated and monitored by a qualified healthcare professional. Patients require regular assessment for metabolic changes, movement disorders, sedation, cardiovascular effects, and overall therapeutic response Frequently utilized in psychiatry clinics, mental health centers, neurology departments, and hospitals Widely prescribed by psychiatrists, neurologists, and mental health specialists for appropriate clinical indications This strengthens a comprehensive CNS and psychiatric care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Risperidone IP 2mg + Trihexyphenidyl Hydrochloride IP 2mg Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Risperidone IP 2mg + Trihexyphenidyl Hydrochloride IP 2mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent prescription demand in the mental healthcare sector, expanding CNS pharmaceutical market opportunities, reliable supply chain support, repeat prescriptions, and attractive margins in the specialty psychiatric segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality CNS and psychiatric products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.